Uncategorized

In a double data drop Thursday, AbbVie touted two clinical trial wins, for Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus.

PTC Therapeutics, Inc. (NASDAQ: PTCT ). Stuart Peltz , Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years.

SQI Diagnostics Inc. announces that certain insiders of the Company, who are also control persons of the Company and collectively own, or exercise control or direction over, an aggregate of 75% of the issued and outstanding common shares.

INVO Bioscience, Inc. today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor to purchase 3,680,000 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules.

Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of James Rice as Executive Vice President for North America.

Biocept, Inc. announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide (NCT05414123).

Oncorus, Inc. today reported fourth quarter and full year 2022 financial results and provided an update on its business.

Leap Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022.

Ryvu Therapeutics reported financial results for the fourth quarter and the full year ended December 31, 2022, and provided a corporate update.

Humacyte, Inc. today announced financial results for the fourth quarter and year ended December 31, 2022, and highlighted recent corporate accomplishments.